1. Multiple sclerosis: pharmacogenomics and personalised drug treatment

   • V. Annibali
   • G. Ristori
   • R. Mechelli

   OriginalPaper Pages: s347 - s349

2. Combination therapy

   • V. Martinelli

   OriginalPaper Pages: s350 - s354

3. Is there or is there not a place for anti-interferon antibodies in the decision making of multiple sclerosis treatment optimisation?

   • N. Grigoriadis
   • G. Deretzi
   • I. Milonas

   OriginalPaper Pages: s355 - s357

4. Italian Multiple Sclerosis Database Network

   • M. Trojano
   • D. Paolicelli
   • for the Italian MSDN group

   OriginalPaper Pages: s358 - s361

5. Methodology of clinical trials in multiple sclerosis

   • D. D. Mitsikostas

   OriginalPaper Pages: s362 - s364

6. Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project

   • S. Bonavita
   • D. Dinacci
   • G. Tedeschi

   OriginalPaper Pages: s365 - s368

7. Interferon after 10 years in patients with multiple sclerosis

   • C. Pozzilli
   • L. Prosperini
   • A. Paolillo

   OriginalPaper Pages: s369 - s372